Recombinant vesicular stomatitis virus-based west Nile vaccine elicits strong humoral and cellular immune responses and protects mice against lethal challenge with the virulent west Nile virus strain LSU-AR01

Vesicular stomatitis virus (VSV) has been extensively utilized as a viral vector system for the induction of protective immune responses against a variety of pathogens. We constructed recombinant VSVs specifying either the Indiana or Chandipura virus G glycoprotein and expressing the West Nile virus...

Descripción completa

Detalles Bibliográficos
Autores principales: Iyer, Arun V., Pahar, Bapi, Boudreaux, Marc J., Wakamatsu, Nobuko, Roy, Alma F., Chouljenko, Vladimir N., Baghian, Abolghasem, Apetrei, Cristian, Marx, Preston A., Kousoulas, Konstantin G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2009
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115407/
https://www.ncbi.nlm.nih.gov/pubmed/19070640
http://dx.doi.org/10.1016/j.vaccine.2008.11.087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115407/
https://www.ncbi.nlm.nih.gov/pubmed/19070640
http://dx.doi.org/10.1016/j.vaccine.2008.11.087

Ejemplares similares